Company / Free Cash Flow
Caris Life Sciences, Inc. Free Cash Flow History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$66.9M
FY2025
5-year range
-$298.4M / $66.9M
FY2023-FY2025
Trend
+126.4%
vs FY2024
Sector context
#92 of 150
Health Care
What the data says
At $67M, Caris Life Sciences, Inc.'s free cash flow ranks #92 of 150 in the Health Care sector. Improved from -$298M to $67M over the past 2 years.
Based on SEC 10-K filings.
$67M in FY2025.
Improved from -$298M to $67M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#92 of 150 in Health CareTop 61% of 150This company $66.9M Sector average $782.1M
▼
-91.4% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 126.4% year-over-year.
- Ranks #92 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $66.9M | +126.4% |
| FY2024 | -$253.6M | +15.0% |
| FY2023 | -$298.4M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026